Clinical data management software is not one product but a set of connected capabilities for capturing, validating, reviewing, and locking trial data. Vendor documentation describes distinct modules: electronic data capture (EDC), randomization and trial supply management (RTSM), electronic patient-reported outcomes (ePRO), and centralized data review. The FDA guidance for electronic systems in clinical investigations adds a regulatory layer, requiring sponsors to document system use, validation, and data flow for each study [3]. This article explains those workflows, the device-category distinctions that matter during procurement, and a hypothetical evaluation example. It does not rank vendors or infer clinical outcomes. Where a capability is described by a named vendor, that attribution is preserved. Unknowns, such as exact pricing or deployment effort, remain stated as unknowns.
What the Software Actually Does
Ennov describes its clinical data management software as supporting EDC, RTSM, and ePRO workflows to capture and validate clinical trial data with consistent governance and traceability [1]. The EDC component is designed for protocol-specific study data with controlled forms and built-in checks to reduce missing or inconsistent entries [1]. That means the software is not a passive repository; it applies edit checks and validation rules during data entry, which shifts some quality control earlier in the workflow. The same documentation notes support for multi-center trials and flexible study build across early-phase, late-phase, and post-marketing programs [1].
The elluminate platform from eClinical Solutions takes a different framing: one platform for clinical and operational data from ingestion to insights across all data sources [2]. Its Data Central module brings trial data from multiple sources into a single system for clinical data management and review [5]. The vendor states that data managers and medical reviewers can access pre-programmed listings, patient profiles, and visualizations, and can raise issues directly from within a visualization [5]. This distinction matters: some products emphasize capture and validation, while others emphasize unifying data that has already been collected elsewhere.
EDC, RTSM, and ePRO Are Separate Workflows
A common procurement error is treating EDC as the entire clinical data management category. Ennov lists EDC, RTSM, and ePRO as distinct tools within a connected environment [1]. RTSM handles randomization and trial supply management, including consistency checks, email alerts, treatment allocation, and blind management [1]. The vendor states that randomization outcomes can be made available within the eCRF, such as treatment arm or required references for dispensing [1]. That integration reduces manual handoffs, but it does not mean the modules are interchangeable.
ePRO is another distinct workflow. Ennov describes configurable questionnaires, a visual analog scale for self-assessments, automated notifications, and real-time access to patient data [1]. The vendor claims the ePRO module is fully integrated with Ennov EDC and is 21 CFR Part 11 compliant [1]. The FDA guidance defines EDC systems as electronic systems designed to collect, manage, and store clinical investigation data in an electronic format [3]. That definition is narrower than the full platform capabilities vendors describe, which is why evaluation teams should map each required workflow to a specific module rather than assuming a single license covers everything.
Documenting Data Flow for a Study
The FDA guidance recommends that sponsors document the electronic systems used for each clinical investigation and include a diagram depicting the flow of data from data creation to final storage [3]. A practical approach is to list each system by function: EDC for eCRF data, RTSM for randomization and supply, ePRO for patient-reported outcomes, and a review platform for centralized data management. For each system, note the validation status, the interface or data transfer method, and the responsible party. The CP-CTNet master data management plan provides a real-world example: it names Medidata Rave as the clinical data management system for all CP-CTNet studies and describes data entry, query response status, and training requirements [7]. That document also states that access is not granted to systems holding participant data until training is complete [7].
Validation and Documentation Requirements
The FDA guidance is nonbinding but describes current agency thinking on electronic systems, records, and signatures in clinical investigations [3]. It states that validation should be applied to system functionality, configurations specific to the clinical trial protocol, customizations, data transfers, and interfaces between systems [3]. For each clinical investigation, the sponsor should document the electronic systems used to create, modify, maintain, archive, retrieve, or transmit pertinent electronic records, along with system requirements [3]. The guidance also recommends a diagram depicting the flow of data from data creation to final storage [3].
The guidance lists documentation areas that may be appropriate based on risk: system setup, installation, and maintenance; system validation; user acceptance testing; change control procedures; user access controls; data migration, retention, backup, recovery, and contingency plans; and alternative data entry methods in case of system unavailability [3]. When validation is performed by an IT service provider, the regulated entity may review the provider's documentation to evaluate whether the system is fit for purpose [3]. This means procurement teams should request validation documentation, not just feature lists, before selecting a system.
Centralized Review and Data Unification
eClinical Solutions positions Data Central as a module within the elluminate Clinical Data Intelligence Platform that provides access to real-time clinical data from numerous sources [5]. The vendor states that users can access pre-programmed listings, patient profiles, and visualizations, and can review, add, or address issues and generate queries with native AI capabilities that prioritize urgent issues [5]. It also describes role-based review, where data and listings are reviewed according to role in the clinical data management software, and records are tracked by role and by updates since last review [5].
Medidata describes its Data Experience as connecting every stage of the clinical data lifecycle, from protocol design to database lock [6]. The vendor lists EDC, imaging, adjudication, RTSM, safety, sensors, coding, consent, and real-world data linkage as operating within a connected ecosystem [6]. Medidata states that all data flows through validated, role-based systems with full audit trails and traceable lineage [6]. These are vendor claims about architecture, not independently verified outcomes. The practical question for a buyer is whether the platform's integration model matches the data sources already in use.
A Hypothetical Evaluation Scenario
Consider a mid-sized CRO running a Phase II oncology trial with 40 sites, a central imaging vendor, and a separate safety database. The evaluation team could map three required workflows: EDC for eCRF capture, RTSM for randomization and supply, and centralized review for reconciling imaging and safety data. Ennov documentation supports EDC, RTSM, and ePRO in a connected environment [1]. eClinical Solutions documentation supports data review and management from any data source through Data Central [5]. The team would then request validation documentation aligned with the FDA guidance areas [3].
This scenario is a suggestion, not a tested comparison. It does not establish which product is faster, cheaper, or more compliant. The CRO would still need to confirm whether the imaging vendor's export format is supported, whether the safety database can be ingested without custom mapping, and what the implementation timeline is. The public documents do not provide customer satisfaction data. eClinical Solutions states that elluminate pricing typically includes a monthly user license fee, support, and an initial implementation and setup fee [2]. The vendor also states that initial Data Central configuration can be completed within days, with some features taking no longer than weeks [5]. The evaluation should therefore treat vendor claims about automation and AI as claims to be verified through a proof of concept, not as established performance facts.
Sources & references
- Clinical Data Management Software | Ennov · en.ennov.com
- elluminate Platform - Clinical Trial & Data Management Software · eclinicalsol.com
- Electronic Systems, Electronic Records, and Electronic Signatures in Clinical Investigations: Questions and Answers · www.fda.gov
- elluminate Platform - Clinical Trial & Data Management Software · www.eclinicalsol.com
- Centralize clinical data management workflows and review - Data Central · www.eclinicalsol.com
- Clinical Data Management Software - Medidata Data Experience · www.medidata.com
- https://cp-ctnet-dmasc.org/static/resources/CP-CTNet_REFGD03_Data_Management_Plan.pdf · cp-ctnet-dmasc.org